Member Log-in

I forgot my password

Not a Member? Register

Resources

Our resource library is a searchable collection of tools and documents related to various technical areas around the Gavi transition. The library consists of research articles, policy briefs, reports, guidebooks, country data, and other resources pertinent to Gavi transition or immunization programs generally. You can filter the resources by topic, type, or country. Some resources are available to LNCT members only and will require logging in to view.

Resources

Results 1 -10 of 26

How to Cost an Immunization Campaign

LOOK AT THIS IF YOU'RE INTERESTED IN:

Examining evidence on what it costs to conduct an immunization campaign.

HOW YOU CAN USE THIS MATERIAL:

Field researchers, country practitioners, and other stakeholders can use these materials to estimate the costs of different immunization campaigns and inform more accurate financial planning, budgeting, and resource mobilization.

OVERVIEW:

The Immunization Costing Action Network (ICAN) has developed methodological guidance to improve evidence generation on what it costs to conduct an immunization campaign,

Continued

Cost of Vaccine Delivery Strategies in Low- and Middle-income Countries During the COVID-19 Pandemic

LOOK AT THIS IF YOU'RE INTERESTED IN:

Examining the cost implications of providing immunization services through a range of strategies in a safe manner during COVID-19.

HOW YOU CAN USE THIS MATERIAL:

Country stakeholders should use these findings to facilitate discussions at the country-level to inform country planning and resource mobilization efforts.

OVERVIEW:

This study, conducted by researchers from ThinkWell and the Harvard T.H.

Continued

Webinar Resources: Using PATH’s Vaccine Cost Calculators to Inform Immunization Decision-making

LOOK AT THIS IF YOU'RE INTERESTED IN:

Learning how PATH’s Vaccine Cost Calculators can help provide an easy way for country-level decision-makers to assess and compare the costs of specific vaccines.

HOW YOU CAN USE THIS MATERIAL:

Country-level decision-makers should use these cost calculators to assess and compare the costs of certain vaccination programs and determine the cost effectiveness and feasibility of introducing the vaccines in their country.

Continued

How to Cost Immunization Programs: A Practical Guide on Primary Data Collection and Analysis

LOOK AT THIS IF YOU'RE INTERESTED IN:

Using methods related to collecting and analyzing primary data from a sample of health facilities to assess costs of routine immunization services.

HOW YOU CAN USE THIS MATERIAL:

Country immunization program staff and their teams can use this practical guidance to assess the costs of routine immunization services, including the delivery costs of those services,

Continued

PATH Brief: Economic Implications of Switching Rotavirus Vaccine Products in Palestine’s Immunization Program

LOOK AT THIS IF YOU'RE INTERESTED IN:

Comparing the overall costs, impact, and cost-effectiveness of both ROTARIX® and ROTAVAC® rotavirus vaccines.

HOW YOU CAN USE THIS MATERIAL:

Country-level decision makers can learn from the experience of Palestine switching from ROTARIX® and ROTAVAC® to determine which vaccine offers the greatest impact and cost-effectiveness in their setting.

OVERVIEW:

The Palestinian Ministry of Health (MOH) introduced the rotavirus vaccine ROTARIX® in its routine immunization program in 2016.

Continued

PATH’s Vaccine Cost Calculators

LOOK AT THIS IF YOU'RE INTERESTED IN:

Learning how PATH’s Vaccine Cost Calculators can help provide an easy way for country-level decision-makers to assess and compare the costs of specific vaccines.

HOW YOU CAN USE THIS MATERIAL:

Country-level decision-makers should use these cost calculators to assess and compare the costs of certain vaccination programs and determine the cost effectiveness and feasibility of introducing the vaccines in their country.

Continued

Assessing the Incremental Costs and Savings of Introducing Electronic Immunization Registries and Stock Management Systems: Evidence from the Better Immunization Data Initiative in Tanzania and Zambia

LOOK AT THIS IF YOU'RE INTERESTED IN:

Assessing the incremental costs of implementing  electronic immunization registry and stock management systems in immunization programs in Tanzania and Zambia.

HOW YOU CAN USE THIS MATERIAL:

For countries interested in implementing or improving electronic immunization registry and stock management system interventions, they can use the data contained in this study to estimate the incremental costs and ensure these costs are included in the immunization budget.

Continued

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30

LOOK AT THIS IF YOU'RE INTERESTED IN:

Examining the return on investment from immunization programs against ten pathogens for ninety-four low- and middle-income countries for the period 2011–30.

HOW YOU CAN USE THIS MATERIAL:

Country policymakers and other decision makers in funding agencies can use the ROI estimates from this study to contribute to resource mobilization efforts for their national immunization programs.

Continued

Immunization Delivery Cost Catalogue (IDCC)

The Immunization Delivery Cost Catalogue (IDCC) is the most comprehensive, current, and standardized global evidence on the cost of delivering vaccines. In January 2017 and again in April 2018 and December 2019, ThinkWell completed a systematic review of the current evidence base on immunization delivery costs (IDC)*. The IDCC was built to answer a question frequently asked by national and global immunization stakeholders: “What are the unit costs of vaccine delivery across different LMICs and through a variety of delivery strategies?”

Continued

Teaching Vaccine Economics Everywhere (TVEE) Course Materials

1.     Health Economics for Vaccines

The process of creating vaccines, manufacturing, distributing, and injecting them into individuals is a complex process requiring multiple decisions by multiple groups and individuals. On the supply side there are pharmaceutical companies, regulatory authorities, distributors, and thousands of health care workers who have to make strategic choices.

Continued

Choose a Language